Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacy-Related Waste Exceeded $403 Billion In 2010 – Express Scripts

Executive Summary

Pharmacy benefits manager Express Scripts reported that in 2010, $403 billion in pharmacy-related waste could have been avoided across three areas – the sales channel, generic utilization and nonadherence to medications.

You may also be interested in...



Medication Non-Adherence To Be Examined By Surgeon General

The HHS Office of the Surgeon General issues a request for information regarding the non-adherence of prescription medication. However, it is unclear how it plans to use the information once it is collected.

Pharma News, In Brief

Medicare ESRD Performance Measures

Health IT Holds Potential To Improve Medication Adherence – CVS Caremark

Results from a recent study show that the use of health information technology holds the potential to improve medication adherence, but more research needs to be completed to determine what benefits technology can deliver in that area.

Related Content

Topics

UsernamePublicRestriction

Register

PS053361

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel